01 4TENAPANOR HYDROCHLORIDE
01 4ARDELYX INC
01 4TABLET;ORAL
01 1EQ 10MG BASE
02 1EQ 20MG BASE
03 1EQ 30MG BASE
04 1EQ 50MG BASE
01 4USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : IBSRELA
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2019-09-12
Application Number : 211801
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : XPHOZAH
Dosage Strength : EQ 10MG BASE
Packaging :
Approval Date : 2023-10-17
Application Number : 213931
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : XPHOZAH
Dosage Strength : EQ 20MG BASE
Packaging :
Approval Date : 2023-10-17
Application Number : 213931
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : XPHOZAH
Dosage Strength : EQ 30MG BASE
Packaging :
Approval Date : 2023-10-17
Application Number : 213931
Regulatory Info : RX
Registration Country : USA
LOOKING FOR A SUPPLIER?